chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Actinomyces test positive, Acute respiratory failure, Anaemia, Blood culture positive, Bone marrow disorder
Clinical narrative: This is a 61 yo female with pmh dm2 presented to the hospital 12/10/22 and was admitted to the ICU with necrotizing fasciitis of the labia and groin, HHS, sepsis and acute respiratory failure.  She was treated with ivf and iv insulin.  She has required 4 operations for debridement of necrotizing infection thus far.  She has been treated for covid-19 pneumonia and has completed remdesvir and dexamethasone.  She required mechanical ventilation and has been extubated.  Hospital course complicated by acute bilateral upper and lower DVT, hematology consulted due to concern for HIT/DIC and further evaluation. Negative HIT/DIC workup. Negative inpatient hypercoagulability workup. Anemia is  most probably reactive/hypoproliferative bone marrow response with acute significant infection inflammation. Negative hemolysis, negative iron deficiency.  ID on board and recommend for MRSA, B frag, continue vancomycin through tomorrow, meropenem through 1/31/23. Continue empiric fluconazole. Actinomyces on blood culture. Continue wound care.  Patient accepted to go to LTAC.  We will discharge in stable condition.  Continue with meropenem until January 31.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Coagulation test normal, Debridement, Deep vein thrombosis, Endotracheal intubation
Clinical narrative: This is a 61 yo female with pmh dm2 presented to the hospital 12/10/22 and was admitted to the ICU with necrotizing fasciitis of the labia and groin, HHS, sepsis and acute respiratory failure.  She was treated with ivf and iv insulin.  She has required 4 operations for debridement of necrotizing infection thus far.  She has been treated for covid-19 pneumonia and has completed remdesvir and dexamethasone.  She required mechanical ventilation and has been extubated.  Hospital course complicated by acute bilateral upper and lower DVT, hematology consulted due to concern for HIT/DIC and further evaluation. Negative HIT/DIC workup. Negative inpatient hypercoagulability workup. Anemia is  most probably reactive/hypoproliferative bone marrow response with acute significant infection inflammation. Negative hemolysis, negative iron deficiency.  ID on board and recommend for MRSA, B frag, continue vancomycin through tomorrow, meropenem through 1/31/23. Continue empiric fluconazole. Actinomyces on blood culture. Continue wound care.  Patient accepted to go to LTAC.  We will discharge in stable condition.  Continue with meropenem until January 31.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fournier's gangrene, Heparin-induced thrombocytopenia test, Hyperglycaemic hyperosmolar nonketotic syndrome, Infection, Intensive care
Clinical narrative: This is a 61 yo female with pmh dm2 presented to the hospital 12/10/22 and was admitted to the ICU with necrotizing fasciitis of the labia and groin, HHS, sepsis and acute respiratory failure.  She was treated with ivf and iv insulin.  She has required 4 operations for debridement of necrotizing infection thus far.  She has been treated for covid-19 pneumonia and has completed remdesvir and dexamethasone.  She required mechanical ventilation and has been extubated.  Hospital course complicated by acute bilateral upper and lower DVT, hematology consulted due to concern for HIT/DIC and further evaluation. Negative HIT/DIC workup. Negative inpatient hypercoagulability workup. Anemia is  most probably reactive/hypoproliferative bone marrow response with acute significant infection inflammation. Negative hemolysis, negative iron deficiency.  ID on board and recommend for MRSA, B frag, continue vancomycin through tomorrow, meropenem through 1/31/23. Continue empiric fluconazole. Actinomyces on blood culture. Continue wound care.  Patient accepted to go to LTAC.  We will discharge in stable condition.  Continue with meropenem until January 31.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical ventilation, Necrotising soft tissue infection, Sepsis
Clinical narrative: This is a 61 yo female with pmh dm2 presented to the hospital 12/10/22 and was admitted to the ICU with necrotizing fasciitis of the labia and groin, HHS, sepsis and acute respiratory failure.  She was treated with ivf and iv insulin.  She has required 4 operations for debridement of necrotizing infection thus far.  She has been treated for covid-19 pneumonia and has completed remdesvir and dexamethasone.  She required mechanical ventilation and has been extubated.  Hospital course complicated by acute bilateral upper and lower DVT, hematology consulted due to concern for HIT/DIC and further evaluation. Negative HIT/DIC workup. Negative inpatient hypercoagulability workup. Anemia is  most probably reactive/hypoproliferative bone marrow response with acute significant infection inflammation. Negative hemolysis, negative iron deficiency.  ID on board and recommend for MRSA, B frag, continue vancomycin through tomorrow, meropenem through 1/31/23. Continue empiric fluconazole. Actinomyces on blood culture. Continue wound care.  Patient accepted to go to LTAC.  We will discharge in stable condition.  Continue with meropenem until January 31.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had both shots and still got them / suspected vaccination failure; got and dealing with them now/ horrible flare ups; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's comments: This case was reported by the patient via interactive digital media. The reporter stated that he/she had both sets of shots and still had them and was still dealing with them at the time of reporting. The flare-ups were horrible. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible, as no contact details were available.  As this case had no follow up that could be obtained thus conservatively two doses were coded based on reported verbatim without dose number as the patient received 2 sets but number of doses was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Conjunctivitis, Facial paralysis, Myasthenia gravis
Clinical narrative: I did not have an adverse reaction to the vaccine. On 03/23/2022 is when I started feeling a drooping eyelid on my left eye. I went to my doctor, and I had conjunctivitis. I was referred to other doctors for diagnosis. I was diagnosed with myasthenia gravis primarily in my eyes. It is a chronic autoimmune disease that will not get better.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, FLU4, MMRV
Symptoms: Expired product administered, Product administration error
Clinical narrative: Vaccine admin error:  Administered expired Proquad vaccine  (had expired within a week before) making the dose invalid,  Patient/parent notified and will return to revaccinate with an appropriate dose in 3 months.
Age: 8.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received 2 bivalent booster vaccines. Pt parents were informed, his physician was informed.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: had both shots and still got it / suspected vaccination failure; still got it; it is very painful; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's comment: This case was reported by the patient via  interactive digital media. The reporter stated that he/she had both shots and still had got it and it was very painful. Additional supportive information: This case was considered as suspected vaccination failure as details regarding, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible, as no contact, details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Had my advanced shot but still got them/suspected vaccination failure; still got them; mild pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and pain were unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had advanced Shingles shot but still got them but not as bad without the vaccine and reported that it was lasted over a month with mild pain, but he/she could not imagine them with real pain. The patient reported that get your shot if you had not and reported that felt sorry for those anti vacciners. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding, primary schedule, laboratory test and time to onset confirming shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available. As the number of doses received was not confirmed hence single suspect was captured with blank dose number.
Sex: F
Vaccine: VARZOS
Symptoms: Gait disturbance, Pain in extremity
Clinical narrative: Very bad pain in feet; Can barely walk; This case was reported by a consumer and described the occurrence of foot pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included ulcerative colitis. Concomitant products included upadacitinib (Rinvoq).   On 22nd August 2022, the patient received Shingrix. On 9th September 2022, 18 days after receiving Shingrix, the patient experienced foot pain and walking difficulty. On an unknown date, the outcome of the foot pain and walking difficulty were not recovered/not resolved.   It was unknown if the reporter considered the foot pain and walking difficulty to be related to Shingrix.     Additional Information: GSK Receipt Date: 25-JAN-2023 Reporter's Comments: The patient self-reported this case. The patient reported that ever since she got the Shingrix shot she had been having very bad pain in her feet that moves around.  The patient said sometimes it was so bad she could barely walk. (Foot pain). The patient said symptoms were not treated.  The reporter was consented to follow up.
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Nausea
Clinical narrative: Severe headache; Nausea; This case was reported by a consumer and described the occurrence of headache in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th January 2023, the patient received Shingrix. On 26th January 2023, less than a day after receiving Shingrix, the patient experienced headache and nausea. On an unknown date, the outcome of the headache and nausea were not recovered/not resolved.   It was unknown if the reporter considered the headache and nausea to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-JAN-2023 Reporter's Comments: The reporter reported that the patient had severe headache, nausea after receiving Shingrix. The patient received any other product. The patient symptoms were not treated. The reporter was consented to follow up.
Sex: F
Vaccine: HEP
Symptoms: Hepatitis B antibody negative, Therapy non-responder
Clinical narrative: No antibodies for Hepatitis B; This case was reported by a consumer via other manufacturer and described the occurrence of therapy non-responder in a female patient who received HBV (Engerix B) for prophylaxis.   Concurrent medical conditions included autoimmune disorder.   On an unknown date, the patient received Engerix B. On an unknown date, more than 2 years after receiving Engerix B, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   Additional Information: GSK receipt date: 23-Jan-2023 Reporter's comment: The reporter is a patient reported an adverse event on behalf of herself. The patient reported five years ago received the Engerix B vaccine, recently healthcare provider tested patient's antibodies and there were none for Hepatitis B. The patient stated suffered from an autoimmune disease. Note: The dose number was not reported hence as per guide worst case scenario was considered and one suspect with blank dose number was coded in case.
Sex: U
Vaccine: VARZOS
Symptoms: Back pain, Pain
Clinical narrative: Behind collarbone, on back, neck, down arm pain; This case was reported by a consumer via interactive digital media and described the occurrence of radiating pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 23rd January 2023, the patient received Shingles vaccine. On 23rd January 2023, less than a day after receiving Shingles vaccine, the patient experienced radiating pain. On an unknown date, the outcome of the radiating pain was unknown.   It was unknown if the reporter considered the radiating pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 23-JAN-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient got his/her Shingles shot today on the day of reporting and reported that behind his/her collarbone on back and it was going up his/her neck and down his/her arm pain. The patient asked was that normal. Additional Supportive Information: Vaccination date and event onset date captured as per narrative. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Inejction site looks like a golf ball; This case was reported by a consumer via interactive digital media and described the occurrence of injection site swelling in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th January 2023, the patient received Shingles vaccine. In January 2023, unknown after receiving Shingles vaccine, the patient experienced injection site swelling. The action taken with Shingles vaccine was unknown. On an unknown date, the outcome of the injection site swelling was not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's comments: The case was reported by the patient via interactive digital media. The patient reporter as he/she got a Shingle shot on Tuesday and the site where he/she got the shot looks like a golf ball. The patient asked how long this would go on for. Additional supportive information: The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pruritus, Scratch, Skin haemorrhage
Clinical narrative: start to bleed; leg started to itch, middle of my back, my lower back; scratched; This case was reported by a consumer via interactive digital media and described the occurrence of skin bleeding in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In December 2022, the patient received the 1st dose of Shingles vaccine. In December 2022, 1 week after receiving Shingles vaccine, the patient experienced skin bleeding, itchy legs and scratch. On an unknown date, the outcome of the skin bleeding, itchy legs and scratch were unknown.   It was unknown if the reporter considered the skin bleeding, itchy legs and scratch to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's Comment: This case was reported by a patient via interactive digital media.  The patient received 1st shot in the first part of December. The reporter reported that about a week after vaccine patients leg, middle of back and lower back start to itch. The patient scratched so much and start to bleed. It did not hurt it was just the itching that drives. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: HEPA
Symptoms: Accidental exposure to product, Exposure via skin contact, Incorrect dose administered
Clinical narrative: Did not receive the full dose/ Syringe cracked, lot of leakage; Syringe cracked, lot of leakage it is possible that it got on the patient's skin since it leaked out.; it is possible that it got on the patient's skin since it leaked out. Syringe cracked, lot of leakage; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a adult patient who received HAV (Havrix) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd January 2023, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 23rd January 2023, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact. On an unknown date, the outcome of the incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-JAN-2023 Reporter's Comment: The pharmacist stated that a nurse was attempting to administer Havrix to patient and cracked the syringe when placing the needle on. The patient did not receive the full dose as there was a lot of leakage around the needle.  It was possible that it got on the patient's skin since it leaked out. The reporter did not know how much of the dose the patient received. The reporter confirmed that the syringe was not cracked upon receipt (no PQC). The patient demographics, lot number, expiration date was not available at this time. The reporter consent to follow up. Additional supportive information: The patient did not receive the full dose of vaccine as there was a lot of leakage around the needle, which led to Incomplete dose administered. It was possible that it got on the patient's skin since it leaked out, which led to exposure via skin contact and inadvertent exposure to vaccine.
Age: 43.0
Sex: M
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: Pediatric dose given to an adult; Pediatric dose given to an adult; This case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 43-year-old male patient who received HAV (Havrix pediatric) (batch number LY35X, expiry date 16th February 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 24th January 2023, the patient received Havrix pediatric and Havrix Pre-Filled Syringe Device. On 24th January 2023, unknown after receiving Havrix pediatric and Havrix Pre-Filled Syringe Device, the patient experienced accidental underdose and adult use of a child product. On an unknown date, the outcome of the accidental underdose and adult use of a child product were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 24-JAN-2023 Reporter's Comments: Medical assistant (MA) reported they inadvertently administered a Havrix pediatric dose to an adult patient. MA confirmed dose was administered in the HCP facility on date of reporting. Medical assistant inquired how to proceed. Did not consent to follow-up. Additional Supportive Information: The adult patient was administered with Havrix pediatric, which led to accidental underdose and adult use of a child product.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Cough, Dyspnoea, Nausea, Renal mass
Clinical narrative: Hospitalized 2/28/22-3/3/22 Abd pain, nausea, cough,  O2, SOB, renal mass, urinary retention
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary retention
Clinical narrative: Hospitalized 2/28/22-3/3/22 Abd pain, nausea, cough,  O2, SOB, renal mass, urinary retention
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cachexia, Chest X-ray, Chronic obstructive pulmonary disease, Chronic respiratory failure
Clinical narrative: The patient is a 63 y.o. male with history of COPD, protein malnutrition presented to Hospital with shortness of breath.   Chronic respiratory failure Acute exacerbation of COPD/COVID infection Ventolin, Doxycycline Received doxycycline 100 IV twice daily Received dexamethasone 6 mg IV daily  Plan for DC home with home health   Covid-19 Virus Infection Date of onset of symptoms: 1/6/2023 Symptoms present on admission: Yes Date of covid positive test: 1/8/2023 Vaccination status: He is not sure Imaging: Chest x-ray Oxygen requirements on admission: Yes Current oxygen requirements: 2L (this is his home level) Medical therapy: remdesivir and steroids Consultants following: ID Anticipated special isolation end date: 1/17/2023   Severe malnutrition w/ cachexia, POA BMI-13.34 Supportive care Ensure booster if needed PT/OT eval  Care manager for DC planning
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Malnutrition, SARS-CoV-2 test positive
Clinical narrative: The patient is a 63 y.o. male with history of COPD, protein malnutrition presented to Hospital with shortness of breath.   Chronic respiratory failure Acute exacerbation of COPD/COVID infection Ventolin, Doxycycline Received doxycycline 100 IV twice daily Received dexamethasone 6 mg IV daily  Plan for DC home with home health   Covid-19 Virus Infection Date of onset of symptoms: 1/6/2023 Symptoms present on admission: Yes Date of covid positive test: 1/8/2023 Vaccination status: He is not sure Imaging: Chest x-ray Oxygen requirements on admission: Yes Current oxygen requirements: 2L (this is his home level) Medical therapy: remdesivir and steroids Consultants following: ID Anticipated special isolation end date: 1/17/2023   Severe malnutrition w/ cachexia, POA BMI-13.34 Supportive care Ensure booster if needed PT/OT eval  Care manager for DC planning
Age: 46.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Blood test, COVID-19, Candida infection, Computerised tomogram, Dyskinesia
Clinical narrative: I started having the worst sore throat I've ever had in my life and a fever; I didn't really have a cough or anything, but I had body aches and fatigue. I developed thrush to mouth sores/COVID-19 tongue. My jaws began locking up and swelling to where I couldn't open my mouth. I went to urgent care where I was tested and diagnosed with COVID-19 on 11/29/2022. The physician told me to remain active so it wouldn't progressively get worse and become pneumonia. The next day, my doctor prescribed me PAXLOVID to help with treatment and told me to let it run its course. They told me to gradually remain somewhat active to keep myself from getting sicker. I developed pain in the right side some time later, and doctors believed it was gallstones. After further diagnosis, they determined it was fatty liver that was later determined with the acid reflux I developed as well. Everything has progressed so fast over such a small period of time.
Age: 46.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Endoscopy, Fatigue, Gastrooesophageal reflux disease, Hepatic steatosis, Immunisation reaction
Clinical narrative: I started having the worst sore throat I've ever had in my life and a fever; I didn't really have a cough or anything, but I had body aches and fatigue. I developed thrush to mouth sores/COVID-19 tongue. My jaws began locking up and swelling to where I couldn't open my mouth. I went to urgent care where I was tested and diagnosed with COVID-19 on 11/29/2022. The physician told me to remain active so it wouldn't progressively get worse and become pneumonia. The next day, my doctor prescribed me PAXLOVID to help with treatment and told me to let it run its course. They told me to gradually remain somewhat active to keep myself from getting sicker. I developed pain in the right side some time later, and doctors believed it was gallstones. After further diagnosis, they determined it was fatty liver that was later determined with the acid reflux I developed as well. Everything has progressed so fast over such a small period of time.
Age: 46.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test positive, Stomatitis
Clinical narrative: I started having the worst sore throat I've ever had in my life and a fever; I didn't really have a cough or anything, but I had body aches and fatigue. I developed thrush to mouth sores/COVID-19 tongue. My jaws began locking up and swelling to where I couldn't open my mouth. I went to urgent care where I was tested and diagnosed with COVID-19 on 11/29/2022. The physician told me to remain active so it wouldn't progressively get worse and become pneumonia. The next day, my doctor prescribed me PAXLOVID to help with treatment and told me to let it run its course. They told me to gradually remain somewhat active to keep myself from getting sicker. I developed pain in the right side some time later, and doctors believed it was gallstones. After further diagnosis, they determined it was fatty liver that was later determined with the acid reflux I developed as well. Everything has progressed so fast over such a small period of time.
Age: 46.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Swelling face, Trismus, Ultrasound scan
Clinical narrative: I started having the worst sore throat I've ever had in my life and a fever; I didn't really have a cough or anything, but I had body aches and fatigue. I developed thrush to mouth sores/COVID-19 tongue. My jaws began locking up and swelling to where I couldn't open my mouth. I went to urgent care where I was tested and diagnosed with COVID-19 on 11/29/2022. The physician told me to remain active so it wouldn't progressively get worse and become pneumonia. The next day, my doctor prescribed me PAXLOVID to help with treatment and told me to let it run its course. They told me to gradually remain somewhat active to keep myself from getting sicker. I developed pain in the right side some time later, and doctors believed it was gallstones. After further diagnosis, they determined it was fatty liver that was later determined with the acid reflux I developed as well. Everything has progressed so fast over such a small period of time.
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: no symptoms as of now, error found on 2/1/23, patient was given the booster Moderna dose and the first dose in the primary series.  I am currently trying to reach patient, to bring her back into the office, to administer the first dose of the Primary Moderna series, per the recommendations set by Moderna.
Age: 8.0
Sex: M
Vaccine: TD
Symptoms: Expired product administered
Clinical narrative: Expired Td vaccine was administered. Vaccine was administered on 1/26/23, expiration date was 1/22/23. Clinic has been unable to reach parent to notify expired vaccine was administered. No further adverse events known at this time.
Age: 7.0
Sex: F
Vaccine: DTAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: no adverse reaction reported
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: patient received a 2nd Bivalent booster after receiving booster on 10/25/22 that was not documented at the time it was given.  Pts PCP advised. Member did not have any reactions.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I received my Covid-19 vaccine on 10/29/2022. On the morning of 12/16/2022 I woke up with a fever sore throat and cough. I tested positive for Covid-19. I then reached to my doctor however i was not prescribed any medications. Symptoms lasted aprox 8  days. after the 8th day I tested negative for Covid-19.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Fatigue, Headache, Vertigo, Vomiting
Clinical narrative: Vertigo (worsened); Dizziness (worsened); Emesis (worsened); Fatigue (worsened); Headache (worsened); This case was reported by a consumer via call center representative and described the occurrence of vertigo in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd January 2023, the patient received the 2nd dose of Shingrix. On 24th January 2023, 2 days after receiving Shingrix, the patient experienced vertigo, dizziness, vomiting, fatigue and headache. On an unknown date, the outcome of the vertigo, dizziness, vomiting, fatigue and headache were not recovered/not resolved.   It was unknown if the reporter considered the vertigo, dizziness, vomiting, fatigue and headache to be related to Shingrix.     Additional Information: GSK Receipt Date: 24-JAN-2023 Reporter's comments: The caller was the patient who had reported that, she had received dose of Shingrix in the left arm. The patient had experienced vertigo, emesis, fatigue, headache, and dizziness. The patient reported that, all the symptoms had begun this morning at the time of reporting and have gotten worse since they had begun.  The reporter had consent to follow-up.
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalization
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Respiratory tract congestion, Urinary tract infection
Clinical narrative: Hospitalized 3/18/22-3/22/22 weakness, cough, congestion, UTI
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Back pain, Condition aggravated, Fatigue
Clinical narrative: Fatigue, arthritis flare evening after shot and worse the follow days (sciatica, back pain, knee pain and instability)
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Sciatica
Clinical narrative: Fatigue, arthritis flare evening after shot and worse the follow days (sciatica, back pain, knee pain and instability)
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood culture negative, COVID-19, Computerised tomogram thorax abnormal, Dyspnoea
Clinical narrative: Patient is a 82 y.o. female patient of MD with history of breast cancer s/p left mastectomy and right lumpectomy, atrial fibrillation, chronic anticoagulation with Eliquis, DM2, HTN presented with shortness of breath with recent COVID 19 positive test results   Acute COVID-19 Virus Infection Possible secondary bacterial pneumonia  Acute hypoxic respiratory failure  Date of onset of symptoms: 12/18/2022 Symptoms present on admission: Shortness of breath, hypoxemia Date of covid positive test: 12/19/2022; repeat for hospitalization on 1/2/2023 Vaccination status: vaccinated ? Imaging: CT pulmonary arteries - no PE; but shows Multifocal pneumonia with reactive lymph nodes in mediastinum and hilum.  ? Influenza negative  ? Blood culture no growth to date  ? Sputum culture no growth to date  ? Pro calcitonin low ? Urine Strep pneumonia Ag negative   Oxygen requirements on admission:6L Oxygen saturation 95% on 2 L nasal cannula Medical therapy:  ? Completed course of Decadron treatment ? Stopped Levaquin 1/5 as no clear bacterial infection  ? Mucinex ? IV lasix for dry lung strategy ? Per Pulm not a candidate for Toci or other immunosuppressant  The patient is clinically improved, isolation can be discontinued. Continue Mucinex, Lasix, oxygen support.          OSA Continue to monitor and treat as needed.   Paroxysmal atrial fibrillation Chronic HFpEF Aortic valve stenosis Hypertension, essential Follows with cardiology Previous cardioversion June 2022 12/12/2021 echo with normal EF Continue Lasix, flecainide, verapamil, and Eliquis.           DM2 July 2022 A1c 6.8 Continue Lantus insulin Continue to monitor the blood sugars and treat as needed with sliding scale coverage.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza virus test negative, Lymphadenopathy, Pneumonia, Procalcitonin decreased, SARS-CoV-2 test positive
Clinical narrative: Patient is a 82 y.o. female patient of MD with history of breast cancer s/p left mastectomy and right lumpectomy, atrial fibrillation, chronic anticoagulation with Eliquis, DM2, HTN presented with shortness of breath with recent COVID 19 positive test results   Acute COVID-19 Virus Infection Possible secondary bacterial pneumonia  Acute hypoxic respiratory failure  Date of onset of symptoms: 12/18/2022 Symptoms present on admission: Shortness of breath, hypoxemia Date of covid positive test: 12/19/2022; repeat for hospitalization on 1/2/2023 Vaccination status: vaccinated ? Imaging: CT pulmonary arteries - no PE; but shows Multifocal pneumonia with reactive lymph nodes in mediastinum and hilum.  ? Influenza negative  ? Blood culture no growth to date  ? Sputum culture no growth to date  ? Pro calcitonin low ? Urine Strep pneumonia Ag negative   Oxygen requirements on admission:6L Oxygen saturation 95% on 2 L nasal cannula Medical therapy:  ? Completed course of Decadron treatment ? Stopped Levaquin 1/5 as no clear bacterial infection  ? Mucinex ? IV lasix for dry lung strategy ? Per Pulm not a candidate for Toci or other immunosuppressant  The patient is clinically improved, isolation can be discontinued. Continue Mucinex, Lasix, oxygen support.          OSA Continue to monitor and treat as needed.   Paroxysmal atrial fibrillation Chronic HFpEF Aortic valve stenosis Hypertension, essential Follows with cardiology Previous cardioversion June 2022 12/12/2021 echo with normal EF Continue Lasix, flecainide, verapamil, and Eliquis.           DM2 July 2022 A1c 6.8 Continue Lantus insulin Continue to monitor the blood sugars and treat as needed with sliding scale coverage.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum culture, Streptococcus test negative, Urine analysis normal, Urine antigen test
Clinical narrative: Patient is a 82 y.o. female patient of MD with history of breast cancer s/p left mastectomy and right lumpectomy, atrial fibrillation, chronic anticoagulation with Eliquis, DM2, HTN presented with shortness of breath with recent COVID 19 positive test results   Acute COVID-19 Virus Infection Possible secondary bacterial pneumonia  Acute hypoxic respiratory failure  Date of onset of symptoms: 12/18/2022 Symptoms present on admission: Shortness of breath, hypoxemia Date of covid positive test: 12/19/2022; repeat for hospitalization on 1/2/2023 Vaccination status: vaccinated ? Imaging: CT pulmonary arteries - no PE; but shows Multifocal pneumonia with reactive lymph nodes in mediastinum and hilum.  ? Influenza negative  ? Blood culture no growth to date  ? Sputum culture no growth to date  ? Pro calcitonin low ? Urine Strep pneumonia Ag negative   Oxygen requirements on admission:6L Oxygen saturation 95% on 2 L nasal cannula Medical therapy:  ? Completed course of Decadron treatment ? Stopped Levaquin 1/5 as no clear bacterial infection  ? Mucinex ? IV lasix for dry lung strategy ? Per Pulm not a candidate for Toci or other immunosuppressant  The patient is clinically improved, isolation can be discontinued. Continue Mucinex, Lasix, oxygen support.          OSA Continue to monitor and treat as needed.   Paroxysmal atrial fibrillation Chronic HFpEF Aortic valve stenosis Hypertension, essential Follows with cardiology Previous cardioversion June 2022 12/12/2021 echo with normal EF Continue Lasix, flecainide, verapamil, and Eliquis.           DM2 July 2022 A1c 6.8 Continue Lantus insulin Continue to monitor the blood sugars and treat as needed with sliding scale coverage.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Choking sensation, Cough, Dizziness, Eye haemorrhage
Clinical narrative: After the vaccine, I've been taking MUCINEX to control my symptoms. I've been coughing daily. When it's cold, I cough more. I had to get a chest x-ray. It came back clean. I've been using my asthma inhaler throughout the day, but I use it mostly at night. Sometimes, when I cough, it feels like I'm choking. Around April of 2022, I was coughing a lot. I made another doctor's appointment because a blood vessel popped in my right eye due to coughing so much. I get migraines throughout the day. The last for multiple days. It feels like pressure in my forehead. Sometimes, I have muscle aches. I also experience dizziness from time to time. I'm to the doctor for the dizziness this month.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Migraine, Myalgia, SARS-CoV-2 test negative
Clinical narrative: After the vaccine, I've been taking MUCINEX to control my symptoms. I've been coughing daily. When it's cold, I cough more. I had to get a chest x-ray. It came back clean. I've been using my asthma inhaler throughout the day, but I use it mostly at night. Sometimes, when I cough, it feels like I'm choking. Around April of 2022, I was coughing a lot. I made another doctor's appointment because a blood vessel popped in my right eye due to coughing so much. I get migraines throughout the day. The last for multiple days. It feels like pressure in my forehead. Sometimes, I have muscle aches. I also experience dizziness from time to time. I'm to the doctor for the dizziness this month.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient was given a Moderna 6M-5Y for the second dose, but the first dose was Pfizer 5-11Y.
Age: 1.25
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event at this moment.  Dr & parent notified
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Blood culture negative, Blood lactic acid decreased, Bronchial secretion retention
Clinical narrative: Patient is a 81 y.o. female patient of local MD with history of  COPD, osteoporosis, squamous cell carcinoma of the tongue, arctic aneurysm, recent diagnosis of PE on Coumadin for anticoagulation is presenting with chief complaint of shortness of breath, cough with green sputum for about a week.     Covid-19 Virus Infection Date of onset of symptoms: A week ago was around 12/18.  Symptoms present on admission: Yes Date of covid positive test: 12/24 Vaccination status: vaccinated Imaging: CTPA?no acute PE with mild bilateral lower lung GGO which could reflect underlying mild pneumonitis.  Borderline prominent heart size with suspected mild pulmonary hypertension.  Extensive bilateral centrilobular and bullous emphysema with large hiatal hernia Oxygen requirements on admission: 3L patient is on 3 L oxygen chronically. Current oxygen requirements: 2-3 lit Medical therapy: Decadron started 12/27 given into no above home O2 demands. Remdesivir started 12/27 per HCP Consultants following: HCP Anticipated special isolation end date:  1/4/23 Breathing improving   Pneumonia- viral  CT pulmonary angiogram shows mild bilateral lower lung groundglass opacities at the right middle, bilateral lower lobes and left lingula.  Findings reflect underlying mild pneumonitis. Afebrile.  Vital stable.  Oxygen saturation 96% on 3 L oxygen. Lactic acid 2.7, WBC 3.8. She was initiated on Rocephin CAP. Procalcitonin <0.06. Stop Rocephin,  Check urine antigen- negative  BC negative at 48 hours Sputum culture normal flora after 24 hrs with heavy growth yeast. Discussed with HCP- likely a commensal mucinex Incentive spirometry/PEP Episode of hemoptysis 1/01- now resolved- likely due to recent pulmonary infection in the setting of AC use Pulmonary consulted. 1/02 CT chest demonstrated developing segmenta and subsegmental bronchial airway endobronchial density likely due to mucus plugging. Mild multifocal bilateral lower lung ground-glass opacities/pneumonitis have intervally decreased when compared to CT 12/24/2022.  Recent history of pulmonary embolism in November 2022 Hemoptysis. She is compliant with Coumadin, INR 2.7-- > 2.5 Patient reports specks of blood in the sputum for last 2 days prior to admission. Now ressolved CT chest as above. Continue Coumadin- dosing per pharmacy.   Given return, consult pulm for evaluation Increase mucinex to 1200mg BID   COPD Chronic respiratory failure She is on 3 L oxygen at baseline. Doxycycline- complete course Resume home inhalers.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Computerised tomogram thorax abnormal, Cough, Dyspnoea, Emphysema
Clinical narrative: Patient is a 81 y.o. female patient of local MD with history of  COPD, osteoporosis, squamous cell carcinoma of the tongue, arctic aneurysm, recent diagnosis of PE on Coumadin for anticoagulation is presenting with chief complaint of shortness of breath, cough with green sputum for about a week.     Covid-19 Virus Infection Date of onset of symptoms: A week ago was around 12/18.  Symptoms present on admission: Yes Date of covid positive test: 12/24 Vaccination status: vaccinated Imaging: CTPA?no acute PE with mild bilateral lower lung GGO which could reflect underlying mild pneumonitis.  Borderline prominent heart size with suspected mild pulmonary hypertension.  Extensive bilateral centrilobular and bullous emphysema with large hiatal hernia Oxygen requirements on admission: 3L patient is on 3 L oxygen chronically. Current oxygen requirements: 2-3 lit Medical therapy: Decadron started 12/27 given into no above home O2 demands. Remdesivir started 12/27 per HCP Consultants following: HCP Anticipated special isolation end date:  1/4/23 Breathing improving   Pneumonia- viral  CT pulmonary angiogram shows mild bilateral lower lung groundglass opacities at the right middle, bilateral lower lobes and left lingula.  Findings reflect underlying mild pneumonitis. Afebrile.  Vital stable.  Oxygen saturation 96% on 3 L oxygen. Lactic acid 2.7, WBC 3.8. She was initiated on Rocephin CAP. Procalcitonin <0.06. Stop Rocephin,  Check urine antigen- negative  BC negative at 48 hours Sputum culture normal flora after 24 hrs with heavy growth yeast. Discussed with HCP- likely a commensal mucinex Incentive spirometry/PEP Episode of hemoptysis 1/01- now resolved- likely due to recent pulmonary infection in the setting of AC use Pulmonary consulted. 1/02 CT chest demonstrated developing segmenta and subsegmental bronchial airway endobronchial density likely due to mucus plugging. Mild multifocal bilateral lower lung ground-glass opacities/pneumonitis have intervally decreased when compared to CT 12/24/2022.  Recent history of pulmonary embolism in November 2022 Hemoptysis. She is compliant with Coumadin, INR 2.7-- > 2.5 Patient reports specks of blood in the sputum for last 2 days prior to admission. Now ressolved CT chest as above. Continue Coumadin- dosing per pharmacy.   Given return, consult pulm for evaluation Increase mucinex to 1200mg BID   COPD Chronic respiratory failure She is on 3 L oxygen at baseline. Doxycycline- complete course Resume home inhalers.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoptysis, Hiatus hernia, International normalised ratio increased, Lung opacity, Malaise
Clinical narrative: Patient is a 81 y.o. female patient of local MD with history of  COPD, osteoporosis, squamous cell carcinoma of the tongue, arctic aneurysm, recent diagnosis of PE on Coumadin for anticoagulation is presenting with chief complaint of shortness of breath, cough with green sputum for about a week.     Covid-19 Virus Infection Date of onset of symptoms: A week ago was around 12/18.  Symptoms present on admission: Yes Date of covid positive test: 12/24 Vaccination status: vaccinated Imaging: CTPA?no acute PE with mild bilateral lower lung GGO which could reflect underlying mild pneumonitis.  Borderline prominent heart size with suspected mild pulmonary hypertension.  Extensive bilateral centrilobular and bullous emphysema with large hiatal hernia Oxygen requirements on admission: 3L patient is on 3 L oxygen chronically. Current oxygen requirements: 2-3 lit Medical therapy: Decadron started 12/27 given into no above home O2 demands. Remdesivir started 12/27 per HCP Consultants following: HCP Anticipated special isolation end date:  1/4/23 Breathing improving   Pneumonia- viral  CT pulmonary angiogram shows mild bilateral lower lung groundglass opacities at the right middle, bilateral lower lobes and left lingula.  Findings reflect underlying mild pneumonitis. Afebrile.  Vital stable.  Oxygen saturation 96% on 3 L oxygen. Lactic acid 2.7, WBC 3.8. She was initiated on Rocephin CAP. Procalcitonin <0.06. Stop Rocephin,  Check urine antigen- negative  BC negative at 48 hours Sputum culture normal flora after 24 hrs with heavy growth yeast. Discussed with HCP- likely a commensal mucinex Incentive spirometry/PEP Episode of hemoptysis 1/01- now resolved- likely due to recent pulmonary infection in the setting of AC use Pulmonary consulted. 1/02 CT chest demonstrated developing segmenta and subsegmental bronchial airway endobronchial density likely due to mucus plugging. Mild multifocal bilateral lower lung ground-glass opacities/pneumonitis have intervally decreased when compared to CT 12/24/2022.  Recent history of pulmonary embolism in November 2022 Hemoptysis. She is compliant with Coumadin, INR 2.7-- > 2.5 Patient reports specks of blood in the sputum for last 2 days prior to admission. Now ressolved CT chest as above. Continue Coumadin- dosing per pharmacy.   Given return, consult pulm for evaluation Increase mucinex to 1200mg BID   COPD Chronic respiratory failure She is on 3 L oxygen at baseline. Doxycycline- complete course Resume home inhalers.